Crohn's disease and Paranasal sinus hypersecretion

Summary:

Paranasal sinus hypersecretion is found among people with Crohn's disease, especially for people who are female, 60+ old.

The study analyzes which people have Paranasal sinus hypersecretion with Crohn's disease. It is created by eHealthMe based on reports of 145 people who have Crohn's disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jul, 22, 2022

145 people who have Crohn'S Disease and Paranasal Sinus Hypersecretion are studied.

What is Crohn's disease?

Crohn's disease (condition that causes inflammation of the gastrointestinal tract) is found to be associated with 2,303 drugs and 1,823 conditions by eHealthMe.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 647 drugs and 373 conditions by eHealthMe.

Number of Paranasal sinus hypersecretion in Crohn's disease reports submitted per year:

Would you have Paranasal sinus hypersecretion when you have Crohn's disease?

Gender of people who have Crohn's disease and experienced Paranasal sinus hypersecretion *:

Click here to view

Age of people who have Crohn's disease and experienced Paranasal sinus hypersecretion *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Crohn's disease (280,043 reports)
Paranasal sinus hypersecretion (3,854 reports)

COVID vaccines that are related to Paranasal sinus hypersecretion:

Common drugs associated with Paranasal sinus hypersecretion:

Aspirin: 203 reports
Enbrel: 867 reports
Humira: 554 reports
Hydrochlorothiazide: 101 reports
Lisinopril: 142 reports
Metformin: 110 reports
Methotrexate: 280 reports
Omeprazole: 108 reports
Prednisone: 236 reports
Repatha: 157 reports
Synthroid: 124 reports
Vitamin d: 114 reports

All the drugs that are associated with Paranasal sinus hypersecretion:

Paranasal sinus hypersecretion (647 drugs)

Common conditions associated with Paranasal sinus hypersecretion:

Blood cholesterol increased: 219 reports
Crohn's disease: 145 reports
High blood cholesterol: 216 reports
High blood pressure: 133 reports
Ldl/hdl ratio increased: 219 reports
Lipoprotein test: 219 reports
Multiple sclerosis: 135 reports
Osteoporosis: 134 reports
Primary pulmonary hypertension: 169 reports
Psoriasis: 263 reports
Psoriatic arthropathy: 210 reports
Ra: 863 reports
Rheumatoid arthritis: 847 reports

All the conditions that are associated with Paranasal sinus hypersecretion:

Paranasal sinus hypersecretion (373 conditions)

How the study uses the data?

The study is based on Paranasal sinus hypersecretion and Crohn's disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.